FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887222479> ?p ?o ?g. }

• W2887222479 endingPage "568" @default.
• W2887222479 startingPage "557" @default.
• W2887222479 abstract "BackgroundChildren with persistent hearing loss due to otitis media with effusion are commonly managed by surgical intervention. A safe, cheap, and effective medical treatment would enhance treatment options. Underpowered, poor-quality trials have found short-term benefit from oral steroids. We aimed to investigate whether a short course of oral steroids would achieve acceptable hearing in children with persistent otitis media with effusion and hearing loss.MethodsIn this individually randomised, parallel, double-blinded, placebo-controlled trial we recruited children aged 2–8 years with symptoms attributable to otitis media with effusion for at least 3 months and with confirmed bilateral hearing loss. Participants were recruited from 20 ear, nose, and throat (ENT), paediatric audiology, and audiovestibular medicine outpatient departments in England and Wales. Participants were randomly allocated (1:1) to sequentially numbered identical prednisolone (oral steroid) or placebo packs by use of computer-generated random permuted block sizes stratified by site and child's age. The primary outcome was audiometry-confirmed acceptable hearing at 5 weeks. All analyses were by intention to treat. This trial is registered with the ISRCTN Registry, number ISRCTN49798431.FindingsBetween March 20, 2014, and April 5, 2016, 1018 children were screened, of whom 389 were randomised. 200 were assigned to receive oral steroids and 189 to receive placebo. Hearing at 5 weeks was assessed in 183 children in the oral steroid group and in 180 in the placebo group. Acceptable hearing was observed in 73 (40%) children in the oral steroid group and in 59 (33%) in the placebo group (absolute difference 7% [95% CI −3 to 17], number needed to treat 14; adjusted odds ratio 1·36 [95% CI 0·88–2·11]; p=0·16). There was no evidence of any significant differences in adverse events or quality-of-life measures between the groups.InterpretationOtitis media with effusion in children with documented hearing loss and attributable symptoms for at least 3 months has a high rate of spontaneous resolution. A short course of oral prednisolone is not an effective treatment for most children aged 2–8 years with persistent otitis media with effusion, but is well tolerated. One in 14 children might achieve improved hearing but not quality of life. Discussions about watchful waiting and other interventions will be supported by this evidence.FundingNational Institute for Health Research (NIHR) Health Technology Assessment programme." @default.
• W2887222479 created "2018-08-22" @default.
• W2887222479 creator A5002227290 @default.
• W2887222479 creator A5011449104 @default.
• W2887222479 creator A5031526787 @default.
• W2887222479 creator A5031619170 @default.
• W2887222479 creator A5035201271 @default.
• W2887222479 creator A5036420519 @default.
• W2887222479 creator A5046065699 @default.
• W2887222479 creator A5049896219 @default.
• W2887222479 creator A5070432856 @default.
• W2887222479 creator A5079149152 @default.
• W2887222479 creator A5082988150 @default.
• W2887222479 creator A5086794112 @default.
• W2887222479 creator A5088289778 @default.
• W2887222479 date "2018-08-01" @default.
• W2887222479 modified "2023-10-02" @default.
• W2887222479 title "Oral steroids for resolution of otitis media with effusion in children (OSTRICH): a double-blinded, placebo-controlled randomised trial" @default.
• W2887222479 cites W1505741973 @default.
• W2887222479 cites W1531488625 @default.
• W2887222479 cites W1559424839 @default.
• W2887222479 cites W1846864735 @default.
• W2887222479 cites W1875948166 @default.
• W2887222479 cites W1965485750 @default.
• W2887222479 cites W2017206704 @default.
• W2887222479 cites W2022966386 @default.
• W2887222479 cites W2027650661 @default.
• W2887222479 cites W2032010130 @default.
• W2887222479 cites W2036341715 @default.
• W2887222479 cites W2061576960 @default.
• W2887222479 cites W2074501218 @default.
• W2887222479 cites W2094841227 @default.
• W2887222479 cites W2102738942 @default.
• W2887222479 cites W2122185155 @default.
• W2887222479 cites W2143103195 @default.
• W2887222479 cites W2168448906 @default.
• W2887222479 cites W2218096687 @default.
• W2887222479 cites W2279482718 @default.
• W2887222479 cites W2319815051 @default.
• W2887222479 cites W2550387860 @default.
• W2887222479 cites W2746660923 @default.
• W2887222479 doi "https://doi.org/10.1016/s0140-6736(18)31490-9" @default.
• W2887222479 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6099122" @default.
• W2887222479 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30152390" @default.
• W2887222479 hasPublicationYear "2018" @default.
• W2887222479 type Work @default.
• W2887222479 sameAs 2887222479 @default.
• W2887222479 citedByCount "26" @default.
• W2887222479 countsByYear W28872224792018 @default.
• W2887222479 countsByYear W28872224792019 @default.
• W2887222479 countsByYear W28872224792020 @default.
• W2887222479 countsByYear W28872224792021 @default.
• W2887222479 countsByYear W28872224792022 @default.
• W2887222479 countsByYear W28872224792023 @default.
• W2887222479 crossrefType "journal-article" @default.
• W2887222479 hasAuthorship W2887222479A5002227290 @default.
• W2887222479 hasAuthorship W2887222479A5011449104 @default.
• W2887222479 hasAuthorship W2887222479A5031526787 @default.
• W2887222479 hasAuthorship W2887222479A5031619170 @default.
• W2887222479 hasAuthorship W2887222479A5035201271 @default.
• W2887222479 hasAuthorship W2887222479A5036420519 @default.
• W2887222479 hasAuthorship W2887222479A5046065699 @default.
• W2887222479 hasAuthorship W2887222479A5049896219 @default.
• W2887222479 hasAuthorship W2887222479A5070432856 @default.
• W2887222479 hasAuthorship W2887222479A5079149152 @default.
• W2887222479 hasAuthorship W2887222479A5082988150 @default.
• W2887222479 hasAuthorship W2887222479A5086794112 @default.
• W2887222479 hasAuthorship W2887222479A5088289778 @default.
• W2887222479 hasBestOaLocation W28872224791 @default.
• W2887222479 hasConcept C126322002 @default.
• W2887222479 hasConcept C141071460 @default.
• W2887222479 hasConcept C142724271 @default.
• W2887222479 hasConcept C163430725 @default.
• W2887222479 hasConcept C168563851 @default.
• W2887222479 hasConcept C187212893 @default.
• W2887222479 hasConcept C202061045 @default.
• W2887222479 hasConcept C204787440 @default.
• W2887222479 hasConcept C27081682 @default.
• W2887222479 hasConcept C2776439223 @default.
• W2887222479 hasConcept C2780283655 @default.
• W2887222479 hasConcept C2780493683 @default.
• W2887222479 hasConcept C2780554537 @default.
• W2887222479 hasConcept C2991744798 @default.
• W2887222479 hasConcept C535046627 @default.
• W2887222479 hasConcept C548259974 @default.
• W2887222479 hasConcept C71924100 @default.
• W2887222479 hasConceptScore W2887222479C126322002 @default.
• W2887222479 hasConceptScore W2887222479C141071460 @default.
• W2887222479 hasConceptScore W2887222479C142724271 @default.
• W2887222479 hasConceptScore W2887222479C163430725 @default.
• W2887222479 hasConceptScore W2887222479C168563851 @default.
• W2887222479 hasConceptScore W2887222479C187212893 @default.
• W2887222479 hasConceptScore W2887222479C202061045 @default.
• W2887222479 hasConceptScore W2887222479C204787440 @default.
• W2887222479 hasConceptScore W2887222479C27081682 @default.
• W2887222479 hasConceptScore W2887222479C2776439223 @default.
• W2887222479 hasConceptScore W2887222479C2780283655 @default.
• W2887222479 hasConceptScore W2887222479C2780493683 @default.

• next